This content is from: Premium

Icahn Alum Alex Denner Thrives on Popping Drug Stocks

Sarissa Capital Management is one of the top performing activists so far this year.

  • By Stephen Taub

      Alex Denner, Sarissa Capital Management (photo credit: Andrew Harrer/Bloomberg) Sarissa Capital Management’s chief investment officer Alexander Denner knows very well that specializing in drug, biotech and other health care stocks can be volatile. This year is a prime example. The Icahn Capital alum and Tiger grandcub runs one of the top-performing

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content